11-58580292-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_053023.5(ZFP91):​c.341+670A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 152,076 control chromosomes in the GnomAD database, including 1,880 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 1880 hom., cov: 32)

Consequence

ZFP91
NM_053023.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.500

Publications

13 publications found
Variant links:
Genes affected
ZFP91 (HGNC:14983): (ZFP91 zinc finger protein, atypical E3 ubiquitin ligase) The protein encoded by this gene is a member of the zinc finger family of proteins. The gene product contains C2H2-type domains, which are the classical zinc finger domains found in numerous nucleic acid-binding proteins. This protein functions as a regulator of the non-canonical NF-kappaB pathway in lymphotoxin-beta receptor signaling. Alternative splicing results in multiple transcript variants. A read-through transcript variant composed of ZFP91 and the downstream CNTF gene sequence has been identified, but it is thought to be non-coding. Read-through transcription of ZFP91 and CNTF has also been observed in mouse. A ZFP91-related pseudogene has also been identified on chromosome 2. [provided by RefSeq, Oct 2010]
ZFP91-CNTF (HGNC:33441): (ZFP91-CNTF readthrough (NMD candidate)) This gene represents a read-through transcript composed of ZFP91 and CNTF sequence. This transcript is thought to be non-coding because it would be subject to nonsense-mediated mRNA decay (NMD). Read-through transcription of ZFP91 and CNTF has also been observed in mouse. [provided by RefSeq, Aug 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.186 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_053023.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZFP91
NM_053023.5
MANE Select
c.341+670A>G
intron
N/ANP_444251.1Q96JP5-1
ZFP91
NM_001197051.2
c.341+670A>G
intron
N/ANP_001183980.1
ZFP91-CNTF
NR_024091.1
n.509+670A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZFP91
ENST00000316059.7
TSL:1 MANE Select
c.341+670A>G
intron
N/AENSP00000339030.5Q96JP5-1
ZFP91-CNTF
ENST00000389919.8
TSL:2
n.341+670A>G
intron
N/AENSP00000455911.1
ZFP91
ENST00000870367.1
c.341+670A>G
intron
N/AENSP00000540426.1

Frequencies

GnomAD3 genomes
AF:
0.148
AC:
22522
AN:
151958
Hom.:
1878
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0746
Gnomad AMI
AF:
0.158
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.147
Gnomad EAS
AF:
0.135
Gnomad SAS
AF:
0.173
Gnomad FIN
AF:
0.216
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.171
Gnomad OTH
AF:
0.161
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.148
AC:
22527
AN:
152076
Hom.:
1880
Cov.:
32
AF XY:
0.152
AC XY:
11265
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.0744
AC:
3090
AN:
41508
American (AMR)
AF:
0.192
AC:
2928
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.147
AC:
510
AN:
3470
East Asian (EAS)
AF:
0.135
AC:
697
AN:
5174
South Asian (SAS)
AF:
0.174
AC:
841
AN:
4822
European-Finnish (FIN)
AF:
0.216
AC:
2272
AN:
10528
Middle Eastern (MID)
AF:
0.204
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
0.171
AC:
11645
AN:
67976
Other (OTH)
AF:
0.161
AC:
340
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
953
1905
2858
3810
4763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.155
Hom.:
2241
Bravo
AF:
0.142
Asia WGS
AF:
0.120
AC:
417
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
1.4
DANN
Benign
0.57
PhyloP100
-0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs948562; hg19: chr11-58347765; API